GHRL and type 2 diabetes mellitus: These unique signaling mechanisms and molecules mediating the insulinostatic action of ghrelin on β-cells provide potential therapeutic targets for the prevention and treatment of type 2 diabetes and hyperinsulinemia [58, 136].